ArticleThe Lancet. Haematology2026

Venetoclax in combination with cytarabine with or without idarubicin or azacitidine in children, adolescents, and young adults with relapsed or refractory acute myeloid leukaemia (VENAML): a multicentre, phase 1 expansion study.

Katelyn P Daniels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.